Sildenafil: an orally active type 5 cyclic GMP-specific phosphodiesterase inhibitor for the treatment of penile erectile dysfunction.
Impact in
Classified as
- Journal
- PubMed
In The Last Decade
doi.org/w90597596 →Countries where authors are citing Sildenafil: an orally active type 5 cyclic GMP-specific phosphodiesterase inhibitor for the treatment of penile erectile dysfunction.
This map shows the geographic impact of Sildenafil: an orally active type 5 cyclic GMP-specific phosphodiesterase inhibitor for the treatment of penile erectile dysfunction.. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sildenafil: an orally active type 5 cyclic GMP-specific phosphodiesterase inhibitor for the treatment of penile erectile dysfunction. with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sildenafil: an orally active type 5 cyclic GMP-specific phosphodiesterase inhibitor for the treatment of penile erectile dysfunction. more than expected).
Fields of papers citing Sildenafil: an orally active type 5 cyclic GMP-specific phosphodiesterase inhibitor for the treatment of penile erectile dysfunction.
This network shows the impact of Sildenafil: an orally active type 5 cyclic GMP-specific phosphodiesterase inhibitor for the treatment of penile erectile dysfunction.. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the Sildenafil: an orally active type 5 cyclic GMP-specific phosphodiesterase inhibitor for the treatment of penile erectile dysfunction..
About Sildenafil: an orally active type 5 cyclic GMP-specific phosphodiesterase inhibitor for the treatment of penile erectile dysfunction.
This paper, published in 1996, received 926 indexed citations . Written by Mitra Boolell, Allen Mj, S Gepi-Attee and Clive Gingell covering the research area of Pediatrics, Perinatology and Child Health, Psychiatry and Mental health and Public Health, Environmental and Occupational Health. It is primarily cited by scholars working on Psychiatry and Mental health (508 citations), Endocrinology, Diabetes and Metabolism (259 citations), Molecular Biology (227 citations), Physiology (102 citations) and Urology (96 citations). Published in PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
This paper is also available at doi.org/w90597596.